Nature's TRAIL—On a Path to Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nature's TRAIL—On a Path to Cancer Immunotherapy

Published:2003-01 Issue:1 Volume:18 Page:1-6
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Smyth Mark J,Takeda Kazuyoshi,Hayakawa Yoshihiro,Peschon Jacques J,van den Brink Marcel R.M,Yagita Hideo

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference37 articles.

1. Targeting death and decoy receptors of the tumour-necrosis factor superfamily;Ashkenazi;Nat. Rev. Cancer,2002

2. Death receptors;Ashkenazi;Science,1998

3. Safety and antitumor activity of recombinant soluble Apo2 ligand;Ashkenazi;J. Clin. Invest.,1999

4. TRAIL receptor-2 signals apoptosis through FADD and caspase-8;Bodmer;Nat. Cell Biol.,2000

5. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach;Burns;J. Biol. Chem.,2001

Cited by 292 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TRIAL-based combination therapies in cancers;International Immunopharmacology;2024-09

2. DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment;Biomedicine & Pharmacotherapy;2024-05

3. TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling;Cells;2024-03-16

4. The Therapeutic Effects of Mesenchymal Stem Cells and their Secretome on Oral Squamous Cell Carcinoma;Current Molecular Medicine;2023-10-18

5. TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content;Frontiers in Immunology;2023-09-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3